Effects of increasing doses of a bolus injection and an intravenous long-term therapy of taurolidine on subcutaneous (metastatic) tumor growth in rats

@article{Braumann2005EffectsOI,
  title={Effects of increasing doses of a bolus injection and an intravenous long-term therapy of taurolidine on subcutaneous (metastatic) tumor growth in rats},
  author={C. Braumann and M. Schoenbeck and C. Menenakos and M. Kilian and C. Jacobi},
  journal={Clinical \& Experimental Metastasis},
  year={2005},
  volume={22},
  pages={77-83}
}
AbstractBackground experimental studies have shown that taurolidine suppresses intraperitoneal tumor growth following local application in rats. In opposite, a single intravenous therapy affected neither intraperitoneal nor subcutaneous growth of malignancies. Thus, an intravenous long-term therapy with taurolidine was investigated in rats after administration of a subcutaneous tumor load. VEGF and TNFα production and their effects on tumor growth have not been elucidated so far. Methods VEGF… Expand
High doses of taurolidine inhibit advanced intraperitoneal tumor growth in rats.
TLDR
The intravenous therapy of 2% TRD is safe and anti-tumorigenic in advanced local tumor growth in rats and does not impair the liver tissue, kidneys, SVC, and leucopoiesis. Expand
Taurolidine: Mode of administration in mouse tumor models
TLDR
The authors failed to determine the maximally tolerated dose (MTD) of taurolidine in the respective wildtype mouse strains prior to commencing this experiment on an osteosarcoma model, and it remains to be seen, whether administration of the MTD i.p. is sufficient to reach the antiproliferative concentration of tauntonidine in plasma. Expand
The tumor suppressive reagent taurolidine inhibits growth of malignant melanoma--a mouse model.
TLDR
Encouraging findings should be further confirmed in clinical studies examining the influence of TRD in patients with disseminated malignant melanoma for whom prognosis still remains dismal. Expand
Wound Healing Is Not Impaired in Rats Undergoing Perioperative Treatment with the Antineoplastic Agent Taurolidine
TLDR
The results suggest that wound healing does not seem to be impaired by TRD in rats, and no relevant impairment of wound healing was observed independent of the different treatment strategies. Expand
Taurolidine: Mode of administration in mouse tumor models
TLDR
The data show that the tauroli-dine doses used in the authors' experiments were in the range of previously reported MTD, and immunocompetent BALB/c and C3H mice used in this study are in general less sensitive to any kind of treatment than immunodeficient mice, which were used in the threepreviously reported tumor models. Expand
Taurolidine in the prevention and therapy of lung metastases.
  • B. Hoksch, B. Rufer, +4 authors R. Schmid
  • Medicine
  • European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery
  • 2009
TLDR
Taurolidine seems to reduce established lung metastases in this in vivo model and may offer additional therapeutic options in patients with colon adenocarcinoma. Expand
Oral administration of the anti-proliferative substance taurolidine has no impact on dextran sulfate sodium induced colitis-associated carcinogenesis in mice
TLDR
Oral administration of TRD has no impact on D SS-induced colitis-associated carcinogenesis, however, SOX9 and Cyclin-D1 representing key members of the Wnt pathway have not yet been described in the DSS-AOM model of carcinogenesis – underlining the importance of this oncogenic pathway in this setting. Expand
Instillation of Taurolidine/Heparin after Laparotomy Reduces Intraperitoneal Tumour Growth in a Colon Cancer Rat Model
TLDR
Taurolidine/heparin effectively reduces intraperitoneal tumour growth when used as an intraoperative lavage during resection of colon cancer. Expand
Divergent effects of taurolidine as potential anti-neoplastic agent: inhibition of bladder carcinoma cells in vitro and promotion of bladder tumor in vivo.
TLDR
Investigation of taurolidine against various human bladder cell lines and the AY-27 rat bladder carcinoma cells showed that instillation into the rat urinary bladder enhanced tumor growth. Expand
The antineoplastic antibiotic taurolidine promotes lung and liver metastasis in two syngeneic osteosarcoma mouse models and exhibits severe liver toxicity
TLDR
The findings of this study question the applicability of taurolidine for OS treatment and may suggest the need for caution regarding the widespread clinical use of t Taurolidine as an antineoplastic agent. Expand
...
1
2
...

References

SHOWING 1-10 OF 27 REFERENCES
Local and systemic chemotherapy with taurolidine and taurolidine/heparin in colon cancer-bearing rats undergoing laparotomy
TLDR
Intraperitoneal therapy of either taurolidine or in combination with heparin inhibits local tumor growth and abdominal wound recurrences in rats undergoing midline laparotomy. Expand
Influence of intraperitoneal and systemic application of taurolidine and taurolidine/heparin during laparoscopy on intraperitoneal and subcutaneous tumour growth in rats
TLDR
Intraperitoneal therapy with taurolidine and the combination with heparin inhibits the intraperitoneal tumour growth and trocar recurrences. Expand
Influence of cytotoxic agents on intraperitoneal tumor implantation after laparoscopy
TLDR
It is suggested that tumor implantation after laparoscopic surgery and port-site metastases might be prevented by the intraperitoneal or systemic administration of cytotoxic agents. Expand
Influence of different gases and intraperitoneal instillation of antiadherent or cytotoxic agents on peritoneal tumor cell growth and implantation with laparoscopic surgery in a rat model
TLDR
T Taurolidine and taurolidine with heparin significantly inhibit intraperitoneal tumor growth, with different gases used for pneumoperitoneum. Expand
Taurolidine Inhibits Tumor Cell Growth In Vitro and In Vivo
TLDR
Taurolidine inhibits the growth of a rat metastatic colorectal tumor cell line in vitro and in vivo and thus may have potential in the prevention of peritoneal metastases. Expand
New Therapeutic Strategies to Avoid Intra- and Extraperitoneal Metastases during Laparoscopy: Results of a Tumor Model in the Rat
TLDR
Heparin slightly inhibits intraperitoneal tumor growth in vivo, while povidone iodine and taurolidine cause a significant decrease in tumor cell growth in vitro as well as intraperitonal tumor Growth in vivo. Expand
Efficacy of cytotoxic agents for the prevention of laparoscopic port-site metastases.
TLDR
The results of this study suggest that the development of metastases to port sites following laparoscopic surgery may be prevented by the intraperitoneal instillation of diluted povodine-iodine. Expand
Use of intraperitoneal 5-fluorouracil and chlorhexidine for prevention of recurrence of perforated colorectal carcinoma in a rat model
TLDR
Intraperitoneal 5-fluorouracil does not significantly decrease recurrence and may increase the risk of abscess when used intraoperatively and chlorhexidine intraperitoneal therapy significantly decreases the frequency of gross tumor recurrence but not total recurrences. Expand
The effect of taurolidine on brain tumor cells.
TLDR
Taurolidine was found to have a direct and selective antineoplastic effect on glial and neuronal brain tumor cells in vitro and indicates an apoptotic mechanism of cell death via currently unknown pathways. Expand
Mechanism and prevention of port-site tumor recurrence after laparoscopy in a murine model.
TLDR
It is concluded that postoperative chemotherapy may be useful in preventing PSR after MIS in patients bearing chemotherapy-sensitive tumors such as neuroblastoma. Expand
...
1
2
3
...